CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-30 | Harris Matthew Scott Chief Medical Officer | Shares withheld for taxes | −2,709 | $9.80 | $27K | 40,568 |
| 2024-01-30 | Harris Matthew Scott Chief Medical Officer | Option exercise · Restricted Stock Units | −9,275 | 27,825 | ||
| 2024-01-30 | Garg Vipin K President and CEO | Option exercise | +26,775 | 276,030 | ||
| 2024-01-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −11,697 | $9.80 | $115K | 264,333 |
| 2024-01-30 | Garg Vipin K President and CEO | Option exercise · Restricted Stock Units | −26,775 | 80,325 | ||
| 2024-01-30 | Eisenstadt Richard I Chief Financial Officer | Option exercise | +9,275 | 42,566 | ||
| 2024-01-30 | Eisenstadt Richard I Chief Financial Officer | Shares withheld for taxes | −2,175 | $9.80 | $21K | 40,391 |
| 2024-01-30 | Eisenstadt Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −9,275 | 27,825 | ||
| 2024-01-25 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Options (option to buy) | +163,200 | 163,200 | ||
| 2024-01-25 | Roberts M Scot Chief Scientific Officer | Grant or award · Restricted Stock Units | +58,400 | 58,400 | ||
| 2024-01-25 | Jordt Raymond M Chief Business Officer | Grant or award · Stock Options (option to buy) | +163,200 | 163,200 | ||
| 2024-01-25 | Jordt Raymond M Chief Business Officer | Grant or award · Restricted Stock Units | +58,400 | 58,400 | ||
| 2024-01-25 | Harris Matthew Scott Chief Medical Officer | Grant or award · Stock Options (option to buy) | +163,200 | 163,200 | ||
| 2024-01-25 | Harris Matthew Scott Chief Medical Officer | Grant or award · Restricted Stock Units | +58,400 | 58,400 | ||
| 2024-01-25 | Garg Vipin K President and CEO | Grant or award · Stock Options (option to buy) | +470,000 | 470,000 | ||
| 2024-01-25 | Garg Vipin K President and CEO | Grant or award · Restricted Stock Units | +168,200 | 168,200 | ||
| 2024-01-25 | Eisenstadt Richard I Chief Financial Officer | Grant or award · Stock Options (option to buy) | +163,200 | 163,200 | ||
| 2024-01-25 | Eisenstadt Richard I Chief Financial Officer | Grant or award · Restricted Stock Units | +58,400 | 58,400 | ||
| 2024-01-01 | Jordt Raymond M Chief Business Officer | Option exercise | +9,375 | 11,207 | ||
| 2024-01-01 | Jordt Raymond M Chief Business Officer | Shares withheld for taxes | −2,503 | $11.25 | $28K | 8,704 |
Page 11 of 29 · 568 trades